RUNX1通过TGFB2-MAPK通路促进子宫癌的扩散
Yongqin Jia1, Neng Yang1, Shuai Tang1
1Department of Obstetrics and Gynecology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Scientific reports
|January 2, 2025
概括
在宫癌 (CC) 中,RUNX1 过度表达,通过通过TGFB2.2激活MAPK通路来促进其进展. 准RUNX1可能为CC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 子宫癌 (CC) 仍然是一个重大的全球健康负担,需要新的治疗目标.
- 在CC中过度表达的RUNX1基因的作用和分子机制尚未完全理解.
研究的目的:
- 阐明RUNX1在宫癌进展中的功能作用.
- 调查RUNX1影响CC的潜在分子机制.
- 评估RUNX1作为宫癌的潜在治疗标.
主要方法:
- 在CC组织中分析RUNX1表达水平和与患者预后的相关性.
- 功能性研究涉及细胞循环进展和增殖试验.
- 使用途径分析 (MAPK) 和基因调制 (TGFB2) 的机制研究.
主要成果:
- 发现RUNX1在CC上升调节,并与预后不佳有关.
- 过度表达RUNX1加速了细胞周期进展和增强了细胞增殖.
- 通过对TGFB2进行上调,RUNX1促进了CC的进展,TGFB2激活了MAPK通路.
结论:
- 在宫癌中,RUNX1作为瘤基因起作用,通过TGFB2/MAPK通路驱动扩散.
- RUNX1也可能通过TGFB2.2影响CC中的瘤免疫微环境.
- RUNX1代表了一种有前途的治疗点,可以改善宫癌的治疗结果.
相关概念视频
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K


